Posted in | News | Nanoelectronics | Nanooptics and Nanophotonics | Nanobusiness

ASM International Finalizes Sale of NanoPhotonics AG

ASM International today announced that it has finalized the sale of its 72.86% interest in NanoPhotonics AG, a company engaged in defect measurement equipment for the semiconductor industry, to Ricmar Beteiligungs GmbH, of Kramsach, Austria. This divestiture is part of ASMI's plan to focus on its core wafer processing portfolio strengths as outlined in its Roadmap to Front-end Peer Group Profitability.

ASMI recorded an impairment charge of €1.4 million related to goodwill of its investment in NanoPhotonics in the 2008 second quarter, and the Company does not expect this transaction to have any additional material impact on its Statement of Operations.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    ASM International. (2019, February 15). ASM International Finalizes Sale of NanoPhotonics AG. AZoNano. Retrieved on April 19, 2024 from https://www.azonano.com/news.aspx?newsID=7922.

  • MLA

    ASM International. "ASM International Finalizes Sale of NanoPhotonics AG". AZoNano. 19 April 2024. <https://www.azonano.com/news.aspx?newsID=7922>.

  • Chicago

    ASM International. "ASM International Finalizes Sale of NanoPhotonics AG". AZoNano. https://www.azonano.com/news.aspx?newsID=7922. (accessed April 19, 2024).

  • Harvard

    ASM International. 2019. ASM International Finalizes Sale of NanoPhotonics AG. AZoNano, viewed 19 April 2024, https://www.azonano.com/news.aspx?newsID=7922.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback